This federal contract award, valued at $1,709.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566613936 DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product.
The contract is a Delivery Order and utilizes a Firm Fixed Price pricing type. It has an ultimate completion date of December 5, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract does not have a set-aside designation, indicating it was awarded through open competition. Amerisourcebergen is the prime contractor, and no major subcontractors are identified. The DLA, a defense agency, is the funding agency for this contract, which supports the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/5/25, 10:13 AM